These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

216 related items for PubMed ID: 8335893

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Staphylococcal enterotoxin B and tumor-necrosis factor-alpha-induced relapses of experimental allergic encephalomyelitis: protection by transforming growth factor-beta and interleukin-10.
    Crisi GM, Santambrogio L, Hochwald GM, Smith SR, Carlino JA, Thorbecke GJ.
    Eur J Immunol; 1995 Nov; 25(11):3035-40. PubMed ID: 7489740
    [Abstract] [Full Text] [Related]

  • 3. Antagonistic effects of endogenous and exogenous TGF-beta and TNF on auto-immune diseases in mice.
    Santambrogio L, Hochwald GM, Leu CH, Thorbecke GJ.
    Immunopharmacol Immunotoxicol; 1993 Aug; 15(4):461-78. PubMed ID: 8227972
    [Abstract] [Full Text] [Related]

  • 4. Experimental allergic encephalomyelitis. T cell trafficking to the central nervous system in a resistant Thy-1 congenic mouse strain.
    Skundric DS, Huston K, Shaw M, Tse HY, Raine CS.
    Lab Invest; 1994 Nov; 71(5):671-9. PubMed ID: 7526038
    [Abstract] [Full Text] [Related]

  • 5. Prevention and treatment of chronic relapsing experimental allergic encephalomyelitis by transforming growth factor-beta 1.
    Racke MK, Dhib-Jalbut S, Cannella B, Albert PS, Raine CS, McFarlin DE.
    J Immunol; 1991 May 01; 146(9):3012-7. PubMed ID: 1707929
    [Abstract] [Full Text] [Related]

  • 6. Successful treatment of experimental allergic encephalomyelitis with transforming growth factor-beta 1.
    Johns LD, Flanders KC, Ranges GE, Sriram S.
    J Immunol; 1991 Sep 15; 147(6):1792-6. PubMed ID: 1716279
    [Abstract] [Full Text] [Related]

  • 7. Interferon gamma, interleukin 4 and transforming growth factor beta in experimental autoimmune encephalomyelitis in Lewis rats: dynamics of cellular mRNA expression in the central nervous system and lymphoid cells.
    Issazadeh S, Mustafa M, Ljungdahl A, Höjeberg B, Dagerlind A, Elde R, Olsson T.
    J Neurosci Res; 1995 Apr 01; 40(5):579-90. PubMed ID: 7602612
    [Abstract] [Full Text] [Related]

  • 8. Anti-T cell monoclonal antibodies in vivo. II. Modulation of acute and chronic experimental allergic encephalomyelitis (EAE) in guinea pigs.
    Sobel RA, Blanchette BW, Russo MA, Williams AM, Colvin RB.
    J Immunol; 1987 Apr 15; 138(8):2507-13. PubMed ID: 3494072
    [Abstract] [Full Text] [Related]

  • 9. Anti-tumor necrosis factor therapy abrogates autoimmune demyelination.
    Selmaj K, Raine CS, Cross AH.
    Ann Neurol; 1991 Nov 15; 30(5):694-700. PubMed ID: 1722388
    [Abstract] [Full Text] [Related]

  • 10. Surgical excision of CNS-draining lymph nodes reduces relapse severity in chronic-relapsing experimental autoimmune encephalomyelitis.
    van Zwam M, Huizinga R, Heijmans N, van Meurs M, Wierenga-Wolf AF, Melief MJ, Hintzen RQ, 't Hart BA, Amor S, Boven LA, Laman JD.
    J Pathol; 2009 Mar 15; 217(4):543-51. PubMed ID: 19023878
    [Abstract] [Full Text] [Related]

  • 11. Latent TGF-beta1-transduced CD4+ T cells suppress the progression of allergic encephalomyelitis.
    Murano M, Xiong X, Murano N, Salzer JL, Lafaille JJ, Tsiagbe VK.
    J Leukoc Biol; 2006 Jan 15; 79(1):140-6. PubMed ID: 16244108
    [Abstract] [Full Text] [Related]

  • 12. Differential expression of TGF-beta, IL-2, and other cytokines in the CNS of Theiler's murine encephalomyelitis virus-infected susceptible and resistant strains of mice.
    Chang JR, Zaczynska E, Katsetos CD, Platsoucas CD, Oleszak EL.
    Virology; 2000 Dec 20; 278(2):346-60. PubMed ID: 11118358
    [Abstract] [Full Text] [Related]

  • 13. Immune invasion of the central nervous system parenchyma and experimental allergic encephalomyelitis, but not leukocyte extravasation from blood, are prevented in macrophage-depleted mice.
    Tran EH, Hoekstra K, van Rooijen N, Dijkstra CD, Owens T.
    J Immunol; 1998 Oct 01; 161(7):3767-75. PubMed ID: 9759903
    [Abstract] [Full Text] [Related]

  • 14. Transforming growth factor beta expression in reactive spinal cord microglia and meningeal inflammatory cells during experimental allergic neuritis.
    Kiefer R, Gold R, Gehrmann J, Lindholm D, Wekerle H, Kreutzberg GW.
    J Neurosci Res; 1993 Nov 01; 36(4):391-8. PubMed ID: 7505838
    [Abstract] [Full Text] [Related]

  • 15. Endogenous CD4+BV8S2- T cells from TG BV8S2+ donors confer complete protection against spontaneous experimental encephalomyelitis (Sp-EAE) in TCR transgenic, RAG-/- mice.
    Matejuk A, Buenafe AC, Dwyer J, Ito A, Silverman M, Zamora A, Subramanian S, Vandenbark AA, Offner H.
    J Neurosci Res; 2003 Jan 01; 71(1):89-103. PubMed ID: 12478617
    [Abstract] [Full Text] [Related]

  • 16. Epicutaneously induced TGF-beta-dependent tolerance inhibits experimental autoimmune encephalomyelitis.
    Szczepanik M, Tutaj M, Bryniarski K, Dittel BN.
    J Neuroimmunol; 2005 Jul 01; 164(1-2):105-14. PubMed ID: 15899524
    [Abstract] [Full Text] [Related]

  • 17. Recovery from experimental allergic encephalomyelitis is TGF-beta dependent and associated with increases in CD4+LAP+ and CD4+CD25+ T cells.
    Zhang X, Reddy J, Ochi H, Frenkel D, Kuchroo VK, Weiner HL.
    Int Immunol; 2006 Apr 01; 18(4):495-503. PubMed ID: 16540527
    [Abstract] [Full Text] [Related]

  • 18. Transforming growth factor-beta enhances the in vivo effector function and memory phenotype of antigen-specific T helper cells in experimental autoimmune encephalomyelitis.
    Weinberg AD, Whitham R, Swain SL, Morrison WJ, Wyrick G, Hoy C, Vandenbark AA, Offner H.
    J Immunol; 1992 Apr 01; 148(7):2109-17. PubMed ID: 1347550
    [Abstract] [Full Text] [Related]

  • 19. High interleukin-10 expression within the central nervous system may be important for initiation of recovery of Dark Agouti rats from experimental autoimmune encephalomyelitis.
    Blaževski J, Petković F, Momčilović M, Jevtic B, Miljković D, Mostarica Stojković M.
    Immunobiology; 2013 Sep 01; 218(9):1192-9. PubMed ID: 23664544
    [Abstract] [Full Text] [Related]

  • 20. Anti-IL-16 therapy reduces CD4+ T-cell infiltration and improves paralysis and histopathology of relapsing EAE.
    Skundric DS, Dai R, Zakarian VL, Bessert D, Skoff RP, Cruikshank WW, Kurjakovic Z.
    J Neurosci Res; 2005 Mar 01; 79(5):680-93. PubMed ID: 15682385
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 11.